This invention pertains to compounds having the structure:whereinm is 0, 1, 2, or 3;R2 is a substituted or unsubstituted imidazole or pyrazole wherein the point of attachment of R2 to the alkyl chain is not N;R5 is a hydrogen atom or a substituted or unsubstituted alkyl, aryl, or alkylaryl moiety; andR7 is a halogen atom, C1-C4 alkyl, OH, O-alkyl(C1-C4), NH2, or NH-alkyl(C1-C4),which specifically inhibit the adenosine A1 and A3 receptors and the use of these compounds to treat a disease associated with A3 adenosine receptor in a subject, comprising administering to the subject a therapeutically effective amount of the compound.